CH | EN

News

News Center

Company News

Industry News

Science Popularization

Video

Jiuzhitang Maker once again listed as a Beijing-based SME specializing in science and technology.

2022-12-01

Recently, in accordance with the provisions of the "Evaluation Measures for Technology-Based Small and Medium-Sized Enterprises" (Guo Ke Fa Zheng [2017] No. 115) and the "Guidelines for Evaluation Services of Technology-Based SMEs" (Guo Ke Huo Zi [2022] No. 67), Jiuzhitang Maker has successfully passed the certification process and has once again been officially included in Beijing's ninth batch of technology-based SMEs for 2022.

Beijing's science and technology-based SMEs are small to medium-sized enterprises that rely on a certain number of science and technology professionals to engage in research and development activities, achieve independent intellectual property rights, and transform these into high-tech products or services—thereby fostering sustainable growth. These SMEs are characterized by their high technological content and strong innovation capabilities, making them dynamic and highly promising players in the innovation ecosystem—and they serve as the main driving force behind the cultivation and development of new growth engines.

Being successfully included again on the list of science and technology-based SMEs is a recognition of Jiuzhitang Maker's innovative capabilities and achievements in areas such as stem cell expansion technology, R&D investment in stem cells, and the commercialization of its proprietary stem cell intellectual property.

Since its establishment, Jiuzhitang Maker has consistently prioritized the cultivation of tech talent and the enhancement of corporate innovation capabilities. Leveraging the advantages of stem cell technology, the company is strengthening its independent innovation competitiveness, striving to secure leadership positions in talent, technology, and innovation—ultimately serving as a powerful catalyst for stem cell-based pharmaceuticals and CQDMO services in the stem cell sector.

The "Implementation Plan for Building the China (Tianjin) Pilot Free Trade Zone's Collaborative Innovation Demonstration Base (Gene and Cell Therapy)" has been officially released.

Featured on the List | Jiuzhitang Maker Receives National High-Tech Enterprise Certification Once Again

Here is the title—h1 placeholder text

Online Message

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Business license